| CASC2 | pancreatic cancer | qRT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32104955 | 2020 |
| CASC2 | oral squamous cell carcinoma | RT-qPCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 32009793 | 2019 |
| CASC2 | esophageal squamous cell carcinoma | qRT-PCR, Western blot, RIP | L | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31728180 | 2019 |
| CASC2 | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay etc | L | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32271431 | 2020 |
| CASC2 | Hepatocellular Carcinoma | qPCR, Luciferase reporter assay, Western blot | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | 31538425 | 2019 |
| CASC2 | pancreatic cancer | Dual-luciferase reporter assay, RT-qPCR, Western blotting | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31894271 | 2020 |
| CASC2 | colorectal cancer | qRT-PCR , Western blot , RIP , in vitro knockdown etc. | H | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31173223 | 2019 |
| CASC2 | oesophageal squamous cell carcinoma | qRT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc. | L | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 31134151 | 2019 |
| CASC2 | oral squamous cell carcinoma | qRT-PCR , Luciferase reporter assay , Western blot etc. | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31123403 | 2019 |
| CASC2 | cervical cancer | qRT-PCR , Western blot etc. | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | 31081078 | 2019 |
| CASC2 | breast cancer | qPCR, Western Blot, Luciferase reporter assay | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30106139 | 2018 |
| CASC2 | oral squamous cell carcinoma | qPCR, Other | L | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | 30467776 | 2019 |
| CASC2 | lung adenocarcinoma | qPCR, RIP, Western blot, Luciferase reporter assay, Other | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | 30450692 | 2018 |
| CASC2 | gastric cancer | qPCR, Luciferase reporter assay, Other | L | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 30372881 | 2018 |
| CASC2 | epithelial ovarian cancer | qPCR, Other | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | 30320385 | 2018 |
| CASC2 | Colorectal Cancer | qPCR, Western blot, in vitro knockdown, RIP, etc. | L | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 30681073 | 2019 |
| CASC2 | Pancreatic cancer | qPCR, Western blot, Luciferase reporter assay, etc. | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | 30675129 | 2019 |
| CASC2 | papillary thyroid cancer | qPCR, Western blot, in vitro knockdown, etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 30609134 | 2019 |
| CASC2 | nasopharyngeal cancer | qPCR, Luciferase reporter assay, RIP, etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 30569153 | 2019 |
| CASC2 | breast cancer | qPCR, Western blot, Luciferase reporter assay | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31352515 | 2019 |
| CASC2 | gastric cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31301415 | 2019 |
| CASC2 | hepatocellular carcinoma | qPCR, Western blot | L | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 31301261 | 2019 |
| CASC2 | oral squamous cell carcinoma | qPCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31210307 | 2019 |
| CASC2 | breast cancer | qPCR, Western blot, in vitro knockdown etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 29523222 | 2018 |
| CASC2 | melanoma | Microarray, qPCR, Western blot, Luciferase reporter assay | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | 29514220 | 2018 |
| CASC2 | malignant melanoma | qPCR, Western blot, Luciferase reporter assay | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 29422114 | 2018 |
| CASC2 | prostate cancer | qPCR, Luciferase reporter assay, in vitro knockdown | L | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 29373811 | 2018 |
| CASC2 | renal cell carcinoma | qPCR, Cell transfection, Dual-luciferase reporter assay, Cell proliferation assay etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 27222255 | 2016 |
| CASC2 | esophageal cancer | qPCR, Luciferase reporter assay, Western blot | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 28964779 | 2017 |
| CASC2 | lung adenocarcinoma | qPCR, Western blot etc. | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 29131257 | 2017 |
| CASC2 | osteosarcoma | qPCR | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✘ | 29257211 | 2017 |
| CASC2 | colorectal cancer | qPCR, Luciferase reporter assay | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 29456985 | 2018 |
| CASC2 | bladder cancer | qPCR;Western blot;etc. | L | ✘ | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 28199978 | 2017 |
| CASC2 | cervical cancer | qPCR, Western blot, Luciferase Reporter Assays | L | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 28495512 | 2017 |
| CASC2 | pancreatic cancer | qPCR, Western blot, Luciferase reporter assay , ChIP etc. | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 28865121 | 2017 |
| CASC2 | non small cell lung cancer | qPCR, Cell transfection, Flow cytometry assay etc. | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 26790438 | 2016 |
| CASC2 | thyroid cancer | qPCR | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 28654795 | 2017 |
| CASC2 | osteosarcoma | qPCR, Western blot | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 29194827 | 2017 |
| CASC2 | colorectal cancer | qPCR, Flow cytometry assay, Cell proliferation assay etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 27198161 | 2016 |
| CASC2 | gastric cancer | qPCR etc. | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | 28849111 | 2017 |
| CASC2 | gastric cancer | qPCR, Cell transfection, Western blot etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | 27648142 | 2016 |
| CASC2 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29476051 | 2018 |
| CASC2 | glioma | qPCR, RNAi, Western blot, RIP, Luciferase reporter assay, MTT assay etc. | L | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 28121023 | 2017 |
| CASC2 | glioma | qPCR, Luciferase reporter assay etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 25446261 | 2014 |
| CASC2 | glioma | qPCR, Luciferase reporter assay, Western blot | L | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 29136760 | 2017 |
| CASC2 | glioma | qPCR, Western blot, Luciferase report assay etc. | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | 28744130 | 2017 |
| CASC2 | hepatocellular carcinoma | qPCR, Western blot etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 29091305 | 2017 |
| CASC2 | hepatocellular carcinoma | qPCR, Western blot etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 28716020 | 2017 |
| CASC2 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 29319182 | 2018 |
| CASC2 | hepatocellular carcinoma | qPCR, Western blot etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 28621238 | 2017 |
| CASC2 | epithelial ovarian cancer | qPCR, Western blot, RIP etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 29571014 | 2018 |
| CASC2 | Glioblastoma | Luciferase reporter assay;RNA immunoprecipitation;etc. | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 32975234 | 2020 |
| CASC2 | Cholangiocarcinoma | qRT-PCR;Western blot;luciferase assay; | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 32894543 | 2020 |